Penumbra (PEN) Depreciation & Amortization (CF) (2014 - 2026)
Penumbra (PEN) posted quarterly Depreciation & Amortization (CF) of $5.6 million for Q2 2026, up 1.96% year-over-year from $5.5 million in Q2 2025, and up 22.76% quarter-over-quarter from $4.6 million in Q1 2026.
Penumbra (PEN) Depreciation & Amortization (CF) (2014 - 2026) Analysis & Trends
Penumbra (PEN) has reported Depreciation & Amortization (CF) for 13 consecutive years, with $5.6 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Depreciation & Amortization (CF) rose 1.96% year-over-year to $5.6 million; the TTM figure through Jun 2026 stood at $17.1 million (down 10.07% YoY), while the FY2025 annual figure was $17.5 million, down 26.29% from the prior year.
- Depreciation & Amortization (CF) climbed to $5.6 million in Q2 2026 per PEN's latest filing, from $4.6 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $7.6 million in Q2 2024 and bottomed at $2.5 million in Q3 2025.
- Historically, Depreciation & Amortization (CF) has averaged $5.7 million across 5 years, with a median of $5.8 million in 2022.
- Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) soared 71.35% — and 2024, when it sank 40.17%.
- Penumbra's Depreciation & Amortization (CF) stood at $6.4 million in 2022, then increased by 9.28% to $7.0 million in 2023, then plunged by 37.66% to $4.4 million in 2024, then rose by 1.66% to $4.5 million in 2025, then grew by 25.87% to $5.6 million in 2026.
- Business Quant data shows PEN's Depreciation & Amortization (CF) at $5.6 million in Q2 2026, $4.6 million in Q1 2026, and $4.5 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 355.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 42.70 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 68.20 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 750.89 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 123.80 Mn |
| 10 | Penumbra | 12.80 Bn | 12.14 Bn | 264.94 Mn | 5.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.62 Mn |
| Jun 30, 2026 | 5.62 Mn |
| Mar 31, 2026 | 4.57 Mn |
| Mar 31, 2026 | 4.57 Mn |
| Dec 31, 2025 | 4.46 Mn |
| Dec 31, 2025 | 4.46 Mn |
| Sep 30, 2025 | 2.49 Mn |
| Sep 30, 2025 | 2.49 Mn |
| Jun 30, 2025 | 5.51 Mn |
| Jun 30, 2025 | 5.51 Mn |
| Mar 31, 2025 | 5.02 Mn |
| Mar 31, 2025 | 5.02 Mn |
| Dec 31, 2024 | 4.39 Mn |
| Dec 31, 2024 | 4.39 Mn |
| Sep 30, 2024 | 4.15 Mn |
| Sep 30, 2024 | 4.15 Mn |
| Jun 30, 2024 | 7.65 Mn |
| Jun 30, 2024 | 7.65 Mn |
| Mar 31, 2024 | 7.52 Mn |
| Mar 31, 2024 | 7.52 Mn |